The FTC yesterday said pharmaceutical companies are delaying generic competition by making patent settlement agreements in which they pledge not to launch their own copycat medicines. The FTC made the comments in a case involving CVS and Rite Aid (RAD), which are suing Pfizer (PFE) and TEVA for conspiring to keep generic versions of the antidepressant Effexor XR out of stores.
The FTC yesterday said pharmaceutical companies are delaying generic competition by making...
From other sites
Video at CNBC.com (Fri, 9:05AM)
Video at CNBC.com (Feb 18, 2015)
Video at CNBC.com (Feb 13, 2015)
Video at CNBC.com (Feb 10, 2015)
at CNBC.com (Jan 13, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs